Our findings strongly support its efficacy, revealing benefits such as lowered heart rate, improved ejection fraction, reduced N-terminal pro-B-type natriuretic peptide (NT-proBNP), and minimized major adverse cardiovascular events (MACE) in AMI patients with HF. Here, NPPB is linked to hydrops fetalis.